Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer.
Huang KW, Hsu FF, Qiu JT, Chern GJ, Lee YA, Chang CC, Huang YT, Sung YC, Chiang CC, Huang RL, Lin CC, Dinh TK, Huang HC, Shih YC, Alson D, Lin CY, Lin YC, Chang PC, Lin SY, Chen Y.
Huang KW, et al. Among authors: chang pc, chang cc.
Sci Adv. 2020 Jan 15;6(3):eaax5032. doi: 10.1126/sciadv.aax5032. eCollection 2020 Jan.
Sci Adv. 2020.
PMID: 31998834
Free PMC article.